Analysis of E-cadherin expression reveals its tumor suppressor role, correlating with poor prognosis in breast cancer.
Conclusions: E-cadherin is a potent tumor suppressor in breast cancer. Its role in disease progression is confirmed by the correlation between partial or complete loss of E-cadherin expression and poor prognosis for patients.
No takes yet. Share an insight, caveat, or question.
Chelpanova et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: